MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Top FDA Milestones and Controversies Under Gottlieb's Watch

Scott Gottlieb, MD, was sworn in as the 23rd commissioner of FDA on May 11, 2017. The medical device industry was quick to throw its support behind Gottlieb after he was picked by President Trump to run the agency.  Gottlieb rattled the industry a month ago with news of his resignation, but nobody can accuse Gottlieb of phoning it in during his final weeks at the agency. He has released 18 official statements since announcing his resignation, and there has been a flurry of other agency activity in that time as well.
Friday marks Scott Gottlieb's final day as FDA commissioner. Here is a review of the key regulatory milestones and controversies that occurred during his time as the agency's 23rd commissioner.
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.